Welcome to LookChem.com Sign In|Join Free

CAS

  • or

825620-23-3

825620-23-3

Post Buying Request

825620-23-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

825620-23-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 825620-23-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,2,5,6,2 and 0 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 825620-23:
(8*8)+(7*2)+(6*5)+(5*6)+(4*2)+(3*0)+(2*2)+(1*3)=153
153 % 10 = 3
So 825620-23-3 is a valid CAS Registry Number.

825620-23-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(4-oxo-2-phenyl-1H-quinolin-7-yl)acetamide

1.2 Other means of identification

Product number -
Other names N-(4-hydroxy-2-phenylquinolin-7-yl)acetamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:825620-23-3 SDS

825620-23-3Downstream Products

825620-23-3Relevant articles and documents

A systematic approach to the optimization of substrate-based inhibitors of the hepatitis C virus NS3 protease: Discovery of potent and specific tripeptide inhibitors

Llinàs-Brunet, Montse,Bailey, Murray D.,Ghiro, Elise,Gorys, Vida,Halmos, Ted,Poirier, Martin,Rancourt, Jean,Goudreau, Nathalie

, p. 6584 - 6594 (2007/10/03)

The inadequate efficacy and tolerability of current therapies for the infectious liver disease caused by the hepatitis C virus have warranted significant efforts in the development of new therapeutics. We have previously reported competitive peptide inhib

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 825620-23-3